Efficacy and safety of surufatinib in unresectable or metastatic grade 3 pancreatic neuroendocrine tumors (NET G3): Real-world analysis. Phase II study of mFOLFIRINOX efficacy as first and subsequent ...

Panelists discuss how careful patient selection and management of potential complications - including surgical risks, device-related adverse events, and cost-benefit considerations requiring operating ...

For everyone who believes health care reform demands action, consider the lack of Congressional response to air traffic control understaffing that affects them directly.

There is decreased risk for MACE, stroke, and mortality in patients with newly diagnosed atrial fibrillation who regularly use statins.

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

A maladaptive stress response might be amenable to behavioral or other interventions to lower future CV risk, say researchers ...

Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

A new study led by researchers at University Hospitals Connor Whole Health found that adults with newly diagnosed sciatica ...

Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, ...

Ruxolitinib cream 1.5% was safe and effective for the treatment of children and adolescents with a 35% or greater body surface areas affected by atopic dermatitis, according to a study.Ruxolitinib ...